We are live on
!
Find out more
SEP
Signature Equity Partners Portfolio holdings
AUM
$218M
Turnover
19.28%
This Fund
S&P 500
This Quarter
Est. Return
+17.82%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$218M
AUM Growth
+$31.5M
(+17%)
Cap. Flow
+$10.7M
Cap. Flow
% of AUM
4.92%
Top 10 Holdings %
Top 10 Hldgs %
24.17%
Holding
1,727
New
177
Increased
579
Reduced
510
Closed
156
Avg Time Held
0.4
years
Top 10 Avg Time Held
0.5
years
Top 20 Avg Time Held
0.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AB Disruptors ETF
FWD
|
+$3.04M |
| 2 |
Apple
AAPL
|
+$1.95M |
| 3 |
Amazon
AMZN
|
+$1.49M |
| 4 |
First Trust Multi-Strategy Alternative ETF
LALT
|
+$1.45M |
| 5 |
JPMorgan International Value ETF
JIVE
|
+$1.38M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
T. Rowe Price Capital Appreciation Equity ETF
TCAF
|
+$1.6M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$1.58M |
| 3 |
Cambria Global Value ETF
GVAL
|
+$1.19M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.03M |
| 5 |
American Beacon GLG Natural Resources ETF
MGNR
|
+$792K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.06% |
| 2 | Technology | 17.06% |
| 3 | Industrials | 6.38% |
| 4 | Financials | 5.38% |
| 5 | Consumer Discretionary | 5.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
951
Medline Inc
MDLN
$32.1B
| $5.92K | ﹤0.01% |
+150
| New | +$6.04K |
2026 Q2
0 quarters
|
|
952
J.M. Smucker
SJM
$13.5B
| $5.89K | ﹤0.01% |
52
-1
| -2% | -$102 |
2025 Q4
2 quarters
|
|
953
Halozyme
HALO
$13.8B
| $5.87K | ﹤0.01% |
75
-45
| -38% | -$3.07K |
2025 Q4
2 quarters
|
|
954
GE HealthCare
GEHC
$31.8B
| $5.82K | ﹤0.01% |
91
-147
| -62% | -$9.66K |
2025 Q4
2 quarters
|
|
955
Seagate
STX
$157B
| $5.79K | ﹤0.01% |
+6
| New | +$4.58K |
2026 Q2
0 quarters
|
|
956
UiPath
PATH
$7.15B
| $5.76K | ﹤0.01% |
530
-297
| -36% | -$3.17K |
2025 Q4
2 quarters
|
|
957
Credit Acceptance
CACC
$5.71B
| $5.73K | ﹤0.01% |
+9
| New | +$4.82K |
2026 Q2
0 quarters
|
|
958
Neurocrine Biosciences
NBIX
$13.9B
| $5.73K | ﹤0.01% |
34
+24
| +240% | +$3.56K |
2025 Q4
2 quarters
|
|
959
Prudential
PUK
$29.6B
| $5.71K | ﹤0.01% |
213
| – | – |
2025 Q4
2 quarters
|
|
960
Kinder Morgan
KMI
$73.1B
| $5.69K | ﹤0.01% |
178
+42
| +31% | +$1.35K |
2025 Q4
2 quarters
|
|
961
Oshkosh
OSK
$7.95B
| $5.67K | ﹤0.01% |
37
-1
| -3% | -$141 |
2025 Q4
2 quarters
|
|
962
NIO
NIO
$8.77B
| $5.64K | ﹤0.01% |
1,115
| – | – |
2025 Q4
2 quarters
|
|
963
ASE Group
ASX
$109B
| $5.64K | ﹤0.01% |
125
-121
| -49% | -$4.06K |
2025 Q4
2 quarters
|
|
964
East-West Bancorp
EWBC
$17.3B
| $5.61K | ﹤0.01% |
43
-25
| -37% | -$3.07K |
2025 Q4
2 quarters
|
|
965
Shake Shack
SHAK
$2.85B
| $5.6K | ﹤0.01% |
100
-100
| -50% | -$7.53K |
2025 Q4
2 quarters
|
|
966
VanEck Long Muni ETF
MLN
$684M
| $5.59K | ﹤0.01% |
314
-92
| -23% | -$1.62K |
2025 Q4
2 quarters
|
|
967
Installed Building Products
IBP
$5B
| $5.55K | ﹤0.01% |
24
-5
| -17% | -$1.22K |
2025 Q4
2 quarters
|
|
968
Enbridge
ENB
$104B
| $5.53K | ﹤0.01% |
102
-18
| -15% | -$987 |
2025 Q4
2 quarters
|
|
969
Roivant Sciences
ROIV
$24.6B
| $5.52K | ﹤0.01% |
+156
| New | +$4.61K |
2026 Q2
0 quarters
|
|
970
AGNC Investment
AGNC
$10.5B
| $5.51K | ﹤0.01% |
506
| – | – |
2026 Q1
1 quarter
|
|
971
Solstice Advanced Materials
SOLS
$9.52B
| $5.5K | ﹤0.01% |
62
+56
| +933% | +$4.62K |
2025 Q4
2 quarters
|
|
972
United States Natural Gas Fund
UNG
$526M
| $5.44K | ﹤0.01% |
+464
| New | +$5.19K |
2026 Q2
0 quarters
|
|
973
PACCAR
PCAR
$58.3B
| $5.41K | ﹤0.01% |
45
-5
| -10% | -$590 |
2025 Q4
2 quarters
|
|
974
Northern Trust
NTRS
$30.3B
| $5.41K | ﹤0.01% |
31
-3
| -9% | -$494 |
2025 Q4
2 quarters
|
|
975
Workday
WDAY
$47.4B
| $5.39K | ﹤0.01% |
44
+1
| +2% | +$127 |
2025 Q4
2 quarters
|
|
Similar funds
FFL
CA
JCA
GIO
XWL
LCWM
TCM
RFO
Signature Equity Partners's Q2 2026 Portfolio in Review
As of Q2 2026, Signature Equity Partners held 1,727 positions worth $218M, up 17% from $186M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Signature Equity Partners deployed $10.7M of net new capital in Q2 2026, opening 177 new positions and adding to 579 existing holdings. Its largest new stake was AB Disruptors ETF: 22,901 shares worth $3.39M.
By sector, the portfolio is most concentrated in Miscellaneous at 55% of assets, down from 56% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was T. Rowe Price Capital Appreciation Equity ETF, an estimated $1.6M trimmed.
- Signature Equity Partners's largest Q2 2026 buy was AB Disruptors ETF: 22,901 shares worth $3.39M.
- Signature Equity Partners added most to Apple in Q2 2026, an estimated $1.95M increase.
- Signature Equity Partners's biggest Q2 2026 reduction was T. Rowe Price Capital Appreciation Equity ETF, cutting an estimated $1.6M.
- Signature Equity Partners fully exited State Street US Sector Rotation ETF in Q2 2026, selling an estimated $169K.
- Signature Equity Partners's ten largest holdings make up 24% of its $218M portfolio in Q2 2026.
- Signature Equity Partners opened 177 new positions and closed 156 in Q2 2026.
- Signature Equity Partners's portfolio value rose 17% quarter-over-quarter to $218M.
Based on Signature Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.